Miraj Sanghvi

Miraj Sanghvi is a Partner at DigiTx Partners, an early-stage venture capital firm based in San Francisco, California. In this role, he leads Seed and Series A investments in the digital health and healthtech sectors, typically writing initial checks ranging from $2 million to $4 million. His recent investment activity includes participating in the February 2025 Seed round for Cerula Care, as well as Series A financings for Rune Labs and CardioSignal in January 2024. Prior to his tenure at DigiTx Partners, Sanghvi gained operational experience at Lifelink Systems, and his current firm operates with strategic ties to Astellas Pharma and MPM Capital. He is actively involved with a broader portfolio of healthcare technology companies, including Eko, Nosus, and Ciba Health. Sanghvi focuses on bridging pharmaceutical expertise with technology-driven investments to scale data analytics and digital therapeutics platforms.